Identification of biomarkers for ER+ breast cancer

Abbreviated Name
Breast: ER+ markers
Lead Investigator
Li, ChristopherFred Hutchinson Cancer Center
Coordinating Investigator
No coordinating investigator
Involved Investigators

Abstract

No abstract availalbe.

Aims

Validation of blood-based biomarkers specific to ER+ breast cancer

Analytic Method

Microarrays and chips

Publications

  • No publications available at this time for this protocol.

Biomarkers

  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
Start Date
Mar 1 2017
Estimated Finish Date
Feb 28 2020
Protocol ID
429
Protocol Type
Collaboration
Fields of Research
  • Other
  • Proteomics
Collaborative Group
Breast and Gynecologic Cancers Research Group
Cancer Types
  • (No cancer types specified)
Phased Status
3

Associated Forms